The lower rate of p63 positivity in muscle‐invasive urothelial carcinomas as compared with non‐muscle‐invasive urothelial neoplasms can be explained by a tumour‐promoting effect of reduced p63 expression. This evidence concerns the gene TP63 and urothelial carcinoma.